What Bear Market? These 2 Stocks Are Killing It.
It's been a sad year for most investors, at least so far. With the S&P 500 in bear market territory (a drop of 20% or more from its most recent highs) and persistent geopolitical and economic problems, it's not clear that the end of these troubles is in sight. But some equities are doing just fine. Let's look at two examples in the biotech industry: Eli Lilly (NYSE: LLY) and Jazz Pharmaceuticals (NASDAQ: JAZZ). Are these stocks worth buying today?
Source Fool.com